The carbon monoxide prodrug oCOm ‐21 increases Ca 2+ sensitivity of the cardiac myofilament
Physiological Reports · 2024
DOI: 10.14814/phy2.15974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2024. Verfasst von Fergus M Payne und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Department of Pharmacology and Toxicology, University of Otago, Dunedin, Otago, New Zealand. Hauptthemen laut MEDLINE: Myofibrils, Carbon Monoxide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Otago (Te Whare Wānanga o Otāgo), Manatu Hauora | Health Research Council of New Zealand (HRC), Health Research Council of New Zealand.
Abstract (Originalsprache)
Patients undergoing cardiopulmonary bypass procedures require inotropic support to improve hemodynamic function and cardiac output. Current inotropes such as dobutamine, can promote arrhythmias, prompting a demand for improved inotropes with little effect on intracellular Ca 2+ flux. Low‐dose carbon monoxide (CO) induces inotropic effects in perfused hearts. Using the CO‐releasing pro‐drug, oCOm‐21, we investigated if this inotropic effect results from an increase in myofilament Ca 2+ sensitivity. Male Sprague Dawley rat left ventricular cardiomyocytes were permeabilized, and myofilament force was measured as a function of ‐log [Ca 2+ ] (pCa) in the range of 9.0–4.5 under five conditions: vehicle, oCOm‐21, the oCOm‐21 control BP‐21, and levosimendan, (9 cells/group). Ca 2+ sensitivity was assessed by the Ca 2+ concentration at which 50% of maximal force is produced (pCa 50 ). oCOm‐21, but not BP‐21 significantly increased pCa 50 compared to vehicle, respectively (pCa 50 5.52 vs. 5.47 vs. 5.44; p < 0.05). No change in myofilament phosphorylation was seen after oCOm‐21 treatment. Pretreatment of cardiomyocytes with the heme scavenger hemopexin, abolished the Ca 2+ sensitizing effect of oCOm‐21. These results support the hypothesis that oCOm‐21‐derived CO increases myofilament Ca 2+ sensitivity through a heme‐dependent mechanism but not by phosphorylation. Further analyses will confirm if this Ca 2+ sensitizing effect occurs in an intact heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Department of Pharmacology and Toxicology, University of Otago, Dunedin, Otago, New Zealand.
- Otago Medical School, Department of Medicine, University of Otago, Dunedin, Otago, New Zealand.
- HeartOtago, University of Otago, Dunedin, New Zealand.
- Department of Kinesiology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- School of Science, Department of Chemistry, University of Otago, Dunedin, Otago, New Zealand.
ORCID-Profile: David S Larsen, Joanne C Harrison, Ivan A Sammut
Förderung
- University of Otago (Te Whare Wānanga o Otāgo)
- Manatu Hauora | Health Research Council of New Zealand (HRC)
- Health Research Council of New Zealand
Zitieren
APA
Payne, F. M., Nie, S., Diffee, G. M., Wilkins, G. T., Larsen, D. S., Harrison, J. C., Baldi, J. C., & Sammut, I. A. (2024). The carbon monoxide prodrug oCOm ‐21 increases Ca 2+ sensitivity of the cardiac myofilament. Physiological Reports. https://doi.org/10.14814/phy2.15974
Vancouver
Payne FM, Nie S, Diffee GM, Wilkins GT, Larsen DS, Harrison JC, et al. The carbon monoxide prodrug oCOm ‐21 increases Ca 2+ sensitivity of the cardiac myofilament. Physiological Reports. 2024. doi:10.14814/phy2.15974
BibTeX
@article{Payne2024,
author = {Payne, Fergus M and Nie, Samantha and Diffee, Gary M and Wilkins, Gerard T and Larsen, David S and Harrison, Joanne C and Baldi, James C and Sammut, Ivan A},
title = {The carbon monoxide prodrug oCOm ‐21 increases Ca 2+ sensitivity of the cardiac myofilament},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.15974}
}
EUVIMED